Akero Therapeutics
AKRO
$19.80
Share price
0.46%
Change (1 day)
-54.93%
Change (1 year)
Categories
Akero Therapeutics (AKRO) - Cash on Hand
Cash on Hand as of December 2023 : $0.55 B
According to Akero Therapeutics's latest financial reports the company has $0.55 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Akero Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.55 B | 56.5% |
| 2022-12-31 | $0.35 B | 86.68% |
| 2021-12-31 | $0.18 B | -29.86% |
| 2020-12-31 | $0.26 B | 96.76% |
| 2019-12-31 | $0.13 B | 79.53% |
| 2018-12-31 | $75.97 M | 12604.85% |
| 2017-12-31 | $0.59 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -62.15% | 🇺🇸 USA |